TOWARDS REFORMING THE TAXONOMY OF HUMAN DISEASE: THE PRECISESADS CROSS SECTIONAL STUDY

dc.conference.dateJUN 13-16, 2018
dc.conference.titleCongress of the European-League-Against-Rheumatism (EULAR)
dc.contributor.authorLaigle, L.
dc.contributor.authorBeretta, L.
dc.contributor.authorWojick, J.
dc.contributor.authorMarovac, J.
dc.contributor.authorPers, J. -O.
dc.contributor.authorLauwerys, B.
dc.contributor.authorFrostegard, J.
dc.contributor.authorMac Donald, F.
dc.contributor.authorJuarez, M.
dc.contributor.authorBenschop, R.
dc.contributor.authorDow, E.
dc.contributor.authorRao, S.
dc.contributor.authorChamberlain, C.
dc.contributor.authorMartin, J.
dc.contributor.authorAlarcon-Riquelme, M. E.
dc.contributor.authorClinical Consortium
dc.contributor.authoraffiliation[Laigle, L.] IRIS, Ctr Therapeut Innovat Immunoinflammatory Dis, Suresnes, France
dc.contributor.authoraffiliation[Beretta, L.] Fdn IRCCS Policlin, Scleroderma Unit, Milan, Italy
dc.contributor.authoraffiliation[Wojick, J.] QuartzBIO SA, Geneva, Switzerland
dc.contributor.authoraffiliation[Marovac, J.] UCB Biopharma, Slough, Berks, England
dc.contributor.authoraffiliation[Juarez, M.] UCB Biopharma, Slough, Berks, England
dc.contributor.authoraffiliation[Chamberlain, C.] UCB Biopharma, Slough, Berks, England
dc.contributor.authoraffiliation[Pers, J. -O.] INSERM, UMR1227, Brest, France
dc.contributor.authoraffiliation[Lauwerys, B.] Clin Univ St Luc, Brussels, Belgium
dc.contributor.authoraffiliation[Lauwerys, B.] Catholic Univ Louvain, Brussels, Belgium
dc.contributor.authoraffiliation[Frostegard, J.] Karolinska Inst, Inst Environm Med, Stockholm, Sweden
dc.contributor.authoraffiliation[Mac Donald, F.] Bayer AG, Berlin, Germany
dc.contributor.authoraffiliation[Benschop, R.] Eli Lilly & Co, Indianapolis, IN 46285 USA
dc.contributor.authoraffiliation[Dow, E.] Eli Lilly & Co, Indianapolis, IN 46285 USA
dc.contributor.authoraffiliation[Rao, S.] Sanoli Aventis Res & Dev, Bridgewater, MA USA
dc.contributor.authoraffiliation[Martin, J.] Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
dc.contributor.authoraffiliation[Alarcon-Riquelme, M. E.] Pfizer Univ, GENYO, Granada, Spain
dc.contributor.funderEU/EFPIA/Innovative Medicines Initiative Joint Undertaking PRECISESADS grant
dc.date.accessioned2025-01-07T17:28:05Z
dc.date.available2025-01-07T17:28:05Z
dc.date.issued2018-06-01
dc.identifier.doi10.1136/annrheumdis-2018-eular.4625
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/77/Suppl_2/1771.3.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/28392
dc.identifier.wosID444351005361
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationCentro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO)
dc.page.number1771-1772
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleTOWARDS REFORMING THE TAXONOMY OF HUMAN DISEASE: THE PRECISESADS CROSS SECTIONAL STUDY
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number77
dc.wostypeMeeting Abstract

Files